Reports First Quarter Revenues of $11.3 Billion Posts First Quarter GAAP Earnings Per Share of $1.07 and Non-GAAP EPS of $2.05; Includes Net Impact of ($0.01) Per Share for GAAP and Non-GAAP EPS Due to Acquired IPRD Charges and Licensing Income Delivers Strong Revenue Growth of 8% from In-Line Products […]
Other News
Northwell Marks Milestone Surgery: More Than 100 Heart Transplants
MANHASSET, N.Y.–(BUSINESS WIRE)–It was a day of celebration and reflection as cardiac doctors, surgeons, nurses and therapists gathered at Sandra Atlas Bass Heart Hospital (SABHH) at North Shore University Hospital (NSUH) on April 26 to celebrate a medial milestone for the health system and region – more than 100 heart transplants have been performed […]
US Heart & Vascular Expands to Kansas through Partnership with Heartland Cardiology
The Heartland Partnership Represents USHV’s First in Kansas. NASHVILLE, Tenn.–(BUSINESS WIRE)–US Heart & Vascular (“USHV”), a leading national provider of support services to cardiovascular physician practices, announced its partnership with Heartland Cardiology (“Heartland”), a Wichita-based cardiovascular physician practice focused on preventative care, diagnostic testing, curative procedures and electrophysiology services. With […]
Baxter Reports First-Quarter 2023 Results
First-quarter revenue of $3.65 billion decreased 2% on a reported basis and increased 2% on a constant currency basis1 First-quarter U.S. GAAP earnings per share (EPS) totaled $0.09; Adjusted EPS totaled $0.59 Baxter expects full-year 2023 sales growth of 1% to 2% on a reported basis and ~1% on a […]
Five-Year Results of the LEOPARD Trial published in the Journal of Vascular Surgery (JVS)
The LEOPARD (Looking at EVAR Outcomes by Primary Analysis of Randomized Data) trial is the first randomized controlled trial (RCT) comparing the outcomes of endovascular aneurysm repair (EVAR) using commercially available devices in a real-world population. IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held global medical device company dedicated to providing disruptive therapies for the interventional treatment […]
10-Year Data from the Medtronic ENGAGE OUS Registry is the First and Only Prospective, Industry Sponsored Global EVAR Registry to Demonstrate a Decade of Durable Outcomes in Real-World Setting
Presented at Charing Cross, 10-Year Clinical Data from Global ENGAGE OUS Registry Support Endurant Stent Graft System’s AAA Market-Leading Position Worldwide Medtronic today announced its EndurantTM abdominal aortic aneurysm (AAA) stent graft system continues to demonstrate long-term durability through proven outcomes in a real-world setting1. The 10-year Endurant Stent Graft Natural Selection […]
Avinger Receives 510(k) Clearance for Tigereye ST Image-Guided CTO Crossing System
REDWOOD CITY, CA / ACCESSWIRE / April 26, 2023 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the first and only intravascular image-guided, catheter-based system for diagnosis and treatment of vascular disease, today announced the company has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for […]
CardieX Receives FDA 510(K) Clearance for a World-First Vascular Biometric Monitor – the CONNEQT Pulse
The world’s first, customizable vascular biometric monitor has received regulatory clearance to provide medical grade arterial heart health metrics to patients and clinicians IRVINE, Calif., April 26, 2023 /PRNewswire/ — CardieX Limited (ASX: CDX) (CardieX, the Company), today announced its new arterial health monitor, the CONNEQT Pulse (Pulse), has received 510(k) clearance from the […]
Ultromics granted FDA Breakthrough Device Designation for AI-enhanced Cardiac Amyloidosis detection
OXFORD, England, April 26, 2023 /PRNewswire/ — Ultromics, a leader in the field of artificial intelligence-powered diagnostics for heart failure, has been granted FDA Breakthrough Device Status for its AI-enhanced platform for detecting cardiac amyloidosis. The platform, EchoGo Amyloidosis, uses artificial intelligence to analyse echocardiograms and detect the presence of cardiac amyloidosis, a […]
Capital Health Now Offers Minimally Invasive Aortic Valve Replacement
HOPEWELL, N.J., April 26, 2023 /PRNewswire/ — As part of the growing full-service cardiac program available at Capital Health’s Heart and Vascular Institute, physicians and staff from the Institute’s Structural Heart Program recently performed their first transcatheter aortic valve replacement (TAVR) procedure at Capital Health Regional Medical Center in Trenton, New Jersey. TAVR […]
Recent
Efemoral Medical Reports Exceptional Long-Term EFEMORAL I Results Highlighting Durability and Differentiated Performance in Femoropopliteal Disease
Xeltis releases groundbreaking new 12-month EU pivotal data for aXess™ demonstrating the transformative potential in hemodialysis treatment
First Peer-Reviewed Study to Evaluate AI-Generated Impressions Demonstrates Radiologist Preference for Domain-Specific Versus General Models
Popular
- No commented posts yet